title: Dialysis-associated increase in the saliva level of paroxetine.
authors.forename: Toshinori
authors.initials: T
authors.lastname: Tsuruta
authors.forename: Keitaro
authors.initials: K
authors.lastname: Tanaka
authors.forename: Kensuke
authors.initials: K
authors.lastname: Ishikawa
authors.forename: Chunyan
authors.initials: C
authors.lastname: Yang
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ueki
authors.forename: Minako
authors.initials: M
authors.lastname: Matsunaga
authors.forename: Hideharu
authors.initials: H
authors.lastname: Tatebayashi
authors.forename: Shigeto
authors.initials: S
authors.lastname: Yamada
mesh_terms: D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D017374:Paroxetine / Q000032:analysis / Q000378:metabolism* / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*; D012463:Saliva / Q000737:chemistry / Q000378:metabolism*
chemical_list: D017374:Paroxetine